Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-660-0 | CAS number: 27794-93-0
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.7 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.7 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.75 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.75 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEL
Local effects
Long term exposure
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Additional information - workers
The DNELs for workers are based on the NOAEL obtained in a 3 -generation oral (dietary) reproductive toxicity study in rats. The NOAEL was ≥275 mg/kg bw/day. The possibility of using the NOAEL from the two-year carcinogenicity study in rats as the starting point for the DNEL calculation was explored. However, this calculation gave higher DNELs and therefore was less sensitive.
The DNELs are based on a NOAEL for the active acid, and as such are applicable to ATMP acid, as well as sodium, potassium and ammonium salts. With regard to the ammonium salt, there are no repeated dose toxicity data on this salt of ATMP. However, administration of this salt can be assumed to lead to the systemic effects observed following the independent administration of ATMP and ammonia (and salts). Therefore the repeated dose toxicity of ammonia is of relevance. In a 13 week repeated-dose feeding study in rats given ammonium sulfate up to 1,975 mg/kg bw/day, no effects were observed on body weight, food consumption or hematological and clinical parameters. However, increased kidney weights (in males and females) and increased liver weights (females) were observed at the highest dose without histopathological changes. The NOAEL was 1,975 mg/kg bw/day for females and 886 mg/kg bw/day for males (diarrhea). Therefore the ammonium salt is not expected to be more toxic than ATMP acid, sodium or potassium salts, and the derived DNELs are adequate to protect against the potential adverse effects of all salts of ATMP.
ATMP ammonium salt is not classified for human health. Aqueous ammonia is subject to formal specific concentration limits for hazard classification according to the CLP regulations. However in ATMP salt preparations the pH falls into a neutral pH range and the proportion of free ammonia in salt products is very small, being dominated by the highly soluble form NH4+which is of low bioavailability. As explained in the ammonia category SIAR, “As pH decreases, the concentration of ammonium ion increases with respect to decreases of unionized ammonia concentrations. However, the toxicity of the unionized ammonia is considered several orders of magnitude greater than the more abundant ammonium ion”. Some relevant toxicity data are available for relevant ammonia salts which would under normal conditions have pH in the neutral range; the pH of the tested substances is not reported but is assumed to be the same.
The NOAEL from oral repeated dose studies with ammonium salts (assumed to have pH in the neutral range) is 250 mg/kg bw/d (based on increased alkaline phosphatase and decreased total protein in blood). There are no effects on reproduction or foetal development. There is an existing inhalatory OEL for ammonia of 14 mg/m3.General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.39 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.39 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEC
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.38 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.38 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEL
Local effects
Long term exposure
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.38 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.38 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEL
General Population - Hazard for the eyes
Additional information - General Population
The DNELs for workers are based on the NOAEL obtained in a 3 -generation oral (dietary) reproductive toxicity study in rats. The NOAEL was≥275 mg/kg bw/day. The possibility of using the NOAEL from the two-year carcinogenicity study in rats as the starting point for the DNEL calculation was explored. However, this calculation gave higher DNELs and therefore was less sensitive.
The DNELs are based on a NOAEL for the active acid, and as such are applicable to ATMP acid, as well as sodium, potassium and ammonium salts. With regard to the ammonium salt, there are no repeated dose toxicity data on this salt of ATMP. However, administration of this salt can be assumed to lead to the systemic effects observed following the independent administration of ATMP and ammonia (and salts). Therefore the repeated dose toxicity of ammonia is of relevance.In a 13 week repeated-dose feeding study in rats given ammonium sulfate up to 1,975 mg/kg bw/day, no effects were observed on body weight, food consumption or hematological and clinical parameters. However, increased kidney weights (in males and females) and increased liver weights (females) were observed at the highest dose without histopathological changes. The NOAEL was 1,975 mg/kg bw/day for females and 886 mg/kg bw/day for males (diarrhea). Therefore the ammonium salt is not expected to be more toxic than ATMP acid, sodium or potassium salts, and the derived DNELs are adequate to protect against the potential adverse effects of all salts of ATMP.
ATMP ammonium salt is not classified for human health. Aqueous ammonia is subject to formal specific concentration limits for hazard classification according to the CLP regulations. However in ATMP salt preparations the pH falls into a neutral pH range and the proportion of free ammonia in salt products is very small, being dominated by the highly soluble form NH4+which is of low bioavailability. As explained in the ammonia category SIAR, “As pH decreases, the concentration of ammonium ion increases with respect to decreases of unionized ammonia concentrations. However, the toxicity of the unionized ammonia is considered several orders of magnitude greater than the more abundant ammonium ion”. Some relevant toxicity data are available for relevant ammonia salts which would under normal conditions have pH in the neutral range; the pH of the tested substances is not reported but is assumed to be the same.
The NOAEL from oral repeated dose studies with ammonium salts (assumed to have pH in the neutral range) is 250 mg/kg bw/d (based on increased alkaline phosphatase and decreased total protein in blood). There are no effects on reproduction or foetal development. There is an existing inhalatory OEL for ammonia of 14 mg/m3.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
